SBIR/STTR Research Award
REGENERATION WITH PDGF TREATED OSTEOCONDUCTIVE MATERIALS
Award amount
$176,905Program and phase
SBIR · Phase IAward year
2001Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- BIOMIMETIC PHARMACEUTICALS, INC.
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- Not reported
- Solicitation number
- Not reported
- Topic code
- Not reported
Research abstract
DESCRIPTION: Platelet derived growth factor-BB (PDGF-BB) has been shown to
stimulate periodontal wound healing in both animals and humans. Certain Bone substitutes
have also been shown to enhance periodontal regeneration in both animal models and
in humans. The investigators have demonstrated that PDGF can be adsorbed to
that PDGF is slowly released in vitro. Addition of PDGF has been shown to enhance the
in vitro osteoblastic cell attachment and proliferation compared to untreated.
The hypothesis of the application is that PDGF treatment will enhance the periodontal
regenerative properties of these osteoconductive materials. The Specific Aims
of the application are to determine if combined with PDGF
promotes greater periodontal regeneration in the beagle dog than unmodified,
to determine the concentration of PDGF that when added to the
stimulates the greatest amount of regeneration, and to
determine if any abnormal healing responses in the periodontal defects such and
ankylosis and root resorption occur with the use of the PDGF treated .
PROPOSED COMMERCIAL APPLICATION: NOT AVAILABLE
Technology keywords
Not reported